Home › High Blood Pressure › Texas › El Paso
High Blood Pressure clinical trials in El Paso, TX
3 studies for High Blood Pressure are looking for participants at sites in and around El Paso (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, El Paso
- Clinical Trial Site, El Paso
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Academy Of Diabetes, Thyroid And Endocrine, PA, El Paso
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Headlands Research-El Paso, El Paso
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX15 studies
- Nashville, TN14 studies
- Birmingham, AL12 studies
- Houston, TX11 studies
- Atlanta, GA10 studies
- Durham, NC10 studies
- Tucson, AZ10 studies
- Rochester, MN9 studies
- Philadelphia, PA9 studies
- Miami, FL9 studies
Other studies in El Paso
- Obesity8 studies
- Breast Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Overweight6 studies
- Heart Failure6 studies
- Metastatic Cancer5 studies
- COPD5 studies
- Idiopathic Pulmonary Fibrosis5 studies
- Burkitt Lymphoma4 studies
- Alzheimer's Disease4 studies
- Migraine4 studies
- Graves Disease4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.